Chemo's hidden toll: study tracks taste loss and muscle wasting in gynecologic cancer patients
NCT ID NCT07154966
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This completed study followed 102 women with ovarian, fallopian tube, or endometrial cancer receiving standard chemotherapy (carboplatin and paclitaxel). Researchers measured taste changes, muscle loss, and nutritional decline at three points during treatment. The goal was to understand how common and severe these side effects are, which could help improve patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ankara Etlik City Hospital
Ankara, Yenimahalle, 06210, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better predict and manage taste changes, muscle loss, and malnutrition in women undergoing chemotherapy for gynecologic cancers.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove that any intervention works, and results may not apply to all patients or cancer types.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.